Immunotherapy
New Research on Neoantigens and Tumor-targeting T-cells Marks Paradigm Shift in Countering Solid Tumors
2021-11-19
AstraZeneca’s Imfinzi, Tremelimumab Combo Significantly Improves Overall Survival in Phase 3 Trials
2021-10-18
Bispecific Antibodies or CAR T-Cells: Which One of These Cancer Immunotherapies Would Prevail?
2021-09-29
ESMO21: Latest Clinical Studies Answer Central Questions in the Treatment of Leading Cancers
2021-09-22
Day 2 ESMO 2021 Roundup: New Paradigms for Long-Term Cancer Care and Immunotherapies for High Risk Metastatic Cancers
2021-09-19
Day 1 ESMO 2021 Roundup: Investigational Immunotherapies Show Promise in Early Cancer Trials
2021-09-18
LATEST
The Targeted Strike – ADCs and Bispecifics Delivering Precision Payloads in Modern Oncology
2026-04-15
Researchers Develop New Method to Detect Extraterrestrial Life by Analyzing Patterns Across Planetary Populations
2026-04-15
Early Patient Involvement in Drug Development Linked to Reduced Costs and Faster Timelines
2026-04-15
Policy, Pricing, and Power: Why Europe’s Biotech Future Depends on Openness, Not Overregulation
2026-04-14
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California





